Faecalibacterium prausnitzii is associated with clinical response to immune checkpoint inhibitors in patients with advanced gastric adenocarcinoma: results of microbiota analysis of PRODIGE 59-FFCD 1707-DURIGAST trial
普氏粪杆菌
医学
内科学
胃肠病学
腺癌
肿瘤科
免疫学
肠道菌群
癌症
作者
Marius Bredon,Karine le Malicot,Christophe Louvet,Ludovic Evesque,Daniel Gonzalez,David Tougeron,Harry Sokol